Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Brain Sci ; 12(5)2022 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-35624942

RESUMEN

BACKGROUND: Glioblastoma (GBM) is the most common primary brain tumor. The extent of resection (EOR) has been claimed as one of the most important prognostic factors. Fluorescent dyes aid surgeons in detecting a tumor's borders. 5-aminolevulinic acid (5-ALA) and sodium fluorescein (SF) are the most used. Only a few studies have directly compared these two fluorophores. METHODS: A single center retrospective analysis of patients treated for GBM in the period between January 2018 and January 2021 was built to find any differences in terms of EOR, Karnofsky Performance Status (KPS), and overall survival (OS) on the use of 5-ALA, SF, or both. RESULTS: Overall, 99 patients affected by isocitrate dehydrogenase (IDH) wild-type Glioblastoma were included. 5-ALA was administered to 40 patients, SF to 44, and both to 15. No statistically significant associations were identified between the fluorophore and EOR (p = 0.783) or postoperative KPS (p = 0.270). Survival analyses did not show a selective advantage for the use of a given fluorophore (p = 0.184), although there appears to be an advantageous trend associated with the concomitant use of both dyes, particularly after stratification by MGMT (p = 0.071). CONCLUSIONS: 5-Ala and SF are equally useful in achieving gross total resection of the enhancing tumor volume. The combination of both fluorophores could lead to an OS advantage.

3.
Neurol Res ; 25(2): 118-22, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12635508

RESUMEN

Extradural motor cortex stimulation was introduced in 1989 for control of central pain. In recent years this has been found useful in several patients with movement disorders. This paper attempts to bring together all the relevant literature, discuss mechanisms and lay out guidelines for future research and clinical applications.


Asunto(s)
Terapia por Estimulación Eléctrica/métodos , Corteza Motora/fisiología , Trastornos del Movimiento/terapia , Adulto , Anciano , Anciano de 80 o más Años , Duramadre , Femenino , Humanos , Masculino , Persona de Mediana Edad
4.
J Neurosurg ; 97(5): 1208-11, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12450046

RESUMEN

Motor cortex stimulation is a minimally invasive surgical procedure used for pain control. The authors report their results treating two patients with typical Parkinson disease. Unilateral motor cortex stimulation proved to be beneficial bilaterally. Motor cortex stimulation may represent a cost-effective alternative to deep brain stimulation.


Asunto(s)
Terapia por Estimulación Eléctrica , Corteza Motora/fisiopatología , Enfermedad de Parkinson/fisiopatología , Enfermedad de Parkinson/terapia , Anciano , Femenino , Humanos , Imagen por Resonancia Magnética , Procedimientos Quirúrgicos Mínimamente Invasivos , Cuidados Paliativos , Enfermedad de Parkinson/diagnóstico , Tomografía Computarizada de Emisión de Fotón Único , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA